bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.13.758927

Dietary vitamin B5 positively regulates intestinal neuropeptide secretion in C. elegans

Jia, Q.·Calof, A.·Sieburth, D.
View original source ↗Export metadata ↓

Abstract

Vitamin B5 is an essential vitamin that must be acquired via diet or by the gut microbiota, and vitamin B5 deficiency or altered vitamin B5 metabolism leads to a variety of physiological and neuronal disorders. We conducted a genetic analysis of the effects of exogenous vitamin B5 in C. elegans, and we found that vitamin B5 confers protection to toxicity caused by oxidative stress and acute exposure to vitamin B5 positively regulates neuropeptide secretion. We identified a sodium-dependent multivitamin transporter family member, smvt-1 that is required for B5 uptake into cells and for protection conferred by vitamin B5. Vitamin B5 positively regulates the intestinal secretion of FLP-2, a neuropeptide-like protein whose release activates the antioxidant response. Vitamin B5 promotes FLP-2 secretion rapidly, specifically, and in a manner that is dependent upon uptake into intestinal cells by smvt-1. Vitamin B5-induced neuropeptide secretion is strictly dependent upon the SNARE protein aex-4/SNAP-25 and on the calcium dependent protein kinase C family member, pkc-2/PKCa in the intestine. These results reveal a previously uncharacterized function for dietary vitamin B5 in positively regulating intestinal neuropeptide secretion from dense core vesicles and in shaping the antioxidant response.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jia, Q., Calof, A., Sieburth, D.. 2026-10-20. Dietary vitamin B5 positively regulates intestinal neuropeptide secretion in C. elegans. https://doi.org/10.64898/2026.10.13.758927

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

B-REAL: A keypoint-less behavior platform for offline classification and real-time detection

Two obstacles limit automated behavior analysis in neuroethology: the burden of first training pose estimation models, and the inability to identify behavior quickly enough for real-time classification that could trigger stimuli, drug delivery, or environmental manipulations. Here we present B-REAL, a pose-free classifier that maps raw video to behavior faster than video frames are recorded, even on a CPU. Given substantially less training data, B-REAL matched or surpassed established methods trained on full benchmark rodent or fly datasets, particularly on rare and even single-frame behaviors. Pretraining on unlabeled video further improves its accuracy without slowing inference or training time. In closed loop, rewarding mice for B-REAL-detected grooming more than doubled their performance of grooming bouts. B-REAL thus makes closed-loop behavioral experiments practical with minimal annotation and standard hardware.

neuroscience↗
bioRxiv2026

Comparing re-referencing methods for human intracranial EEG

Stereo-electroencephalography (SEEG) involves the implantation of depth electrodes in the brain to monitor epileptic seizures for surgical feasibility. As the electrodes advance into deeper limbic structures, the macro contacts distributed along the shaft record electrical activity from more lateral sites, while a bundled array of microwires simultaneously captures highly localised signals from the tip of the electrode. In a clinical setting these electrical signals are recorded relative to a reference signal, which may be sub-optimal for subsequent analyses that are unrelated to clinical objectives. Therefore, a secondary re-referencing operation is often undertaken to transform the signal in relation to a specific hypothesis. Despite a recent surge in SEEG studies, comparative studies on the much-understudied issue of re-referencing are sparse. Here, we analyse data collected from 16 human patients during an episodic memory task and comparatively apply a range of re-referencing methods to both macro contact and micro-wire data. We find that the choice of method changes the proportion of trials that survive artefact rejection, low frequency power, and the aperiodic background against which that power is read. In the hippocampal recordings, however, no method differed from any other in the size of a memory effect in power or spike-field coherence. This early transformative decision therefore bears on how the signal is described. We found no evidence that it changes the detectability of the behavioural effects tested here, and no method reversed the direction of a memory effect.

neuroscience↗
bioRxiv2026

Astrocytic sEH-EET signaling regulates microglial lysosomal function and suppresses the STING-Type I interferon pathway in Alzheimer's disease

Background: The development of {beta}-amyloid (A{beta}) pathology in Alzheimer's disease (AD) is accompanied by profound changes in astrocytes and microglia and associated neuroinflammation. Soluble epoxide hydrolase (sEH), which degrades anti-inflammatory epoxyeicosatrienoic acids (EETs), is elevated in the AD brain, yet how EETs restrain inflammation remains poorly understood. Methods: We performed single-nucleus RNA sequencing (snRNA-seq) on brains from wild-type, sEH knockout, 5xFAD, and 5xFAD; sEH knockout mice, and used primary mouse microglia and human induced pluripotent stem cell (iPSC)-derived microglia to define the underlying mechanism. To test cell-type-specific contributions, we generated astrocyte- and endothelial-specific she knockout mice and crossed them with 5xFAD mice. Results: Genetic disruption of sEH in 5xFAD mice markedly reduced the abundance of a type I interferon (IFN)-responsive microglial subcluster and lowered phospho-STING (pSTING) levels. In primary microglia, supplementation with 11,12-EET attenuated STING activation and IFN target gene expression; blocking lysosomal acidification abolished this effect and caused pSTING to accumulate, identifying lysosomal degradation as a critical route for terminating STING signaling. 11,12-EET also enhanced microglial lysosomal acidification and A{beta} phagocytosis. Astrocytic, but not endothelial, disruption of sEH recapitulated the reductions in A{beta} pathology and microglial STING activation seen in global sEH-deficient mice, identifying astrocytes as the major cellular source of EETs regulating this pathway. Conclusion: We define an astrocyte-microglia axis in which astrocytic sEH limits EET availability and thereby sustains microglial STING signaling. By promoting lysosomal clearance of pSTING, EETs suppress type I IFN signaling and enhance microglial A{beta} clearance, highlighting sEH inhibition as a therapeutic strategy targeting both neuroinflammation and lysosomal dysfunction in AD.

neuroscience↗